Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation. | BMC Med Genomics | 2022 | 35227274 | PubTator, text mining | PubMed |
| The Prognostic Value of Sarcopenia in Acute Myeloid Leukemia Patients and the Development and Validation of a Novel Nomogram for Predicting Survival. | Front Oncol | 2022 | 35223510 | PubTator, text mining | PubMed |
| Identification of a new RNA-binding proteins-based signature for prognostic prediction in gastric cancer. | Medicine (Baltimore) | 2022 | 35212295 | PubTator, text mining | PubMed |
| Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes. | Nat Commun | 2022 | 35210415 | PubTator, text mining | PubMed |
| The PRP19 Ubiquitin Ligase, Standing at the Cross-Roads of mRNA Processing and Genome Stability. | Cancers (Basel) | 2022 | 35205626 | PubTator, text mining | PubMed |
| Promoter-Bound Full-Length Intronic Circular RNAs-RNA Polymerase II Complexes Regulate Gene Expression in the Human Parasite Entamoeba histolytica. | Noncoding RNA | 2022 | 35202086 | PubTator, text mining | PubMed |
| Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. | Curr Oncol | 2022 | 35200567 | PubTator, text mining | PubMed |
| Isolated anemia in patients with large granular lymphocytic leukemia (LGLL). | Blood Cancer J | 2022 | 35194022 | PubTator, text mining | PubMed |
| Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA. | Blood Adv | 2022 | 35192693 | PubTator, text mining | PubMed |
| Updates on Clinical Trials for Myelofibrosis: Highlights From SOHO 2021. | J Adv Pract Oncol | 2022 | 35186404 | PubTator, text mining | PubMed |
| Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy. | J Clin Oncol | 2022 | 35180010 | PubTator, text mining | PubMed |
| Advances in the Treatment of Hairy Cell Leukemia Variant. | Curr Treat Options Oncol | 2022 | 35178674 | PubTator, text mining | PubMed |
| Multi-omics reveals mitochondrial metabolism proteins susceptible for drug discovery in AML. | Leukemia | 2022 | 35177813 | PubTator, text mining | PubMed |
| Chronic neutrophilic leukemia complicated with monoclonal gammopathy of undetermined significance: A case report and literature review. | J Clin Lab Anal | 2022 | 35170077 | PubTator, text mining | PubMed |
| Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling. | J Clin Med | 2022 | 35159934 | PubTator, text mining | PubMed |
| Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review. | Cells | 2022 | 35159389 | PubTator, text mining | PubMed |
| The Genomics of Hairy Cell Leukaemia and Splenic Diffuse Red Pulp Lymphoma. | Cancers (Basel) | 2022 | 35158965 | PubTator, text mining | PubMed |
| Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets. | Cancers (Basel) | 2022 | 35158934 | PubTator, text mining | PubMed |
| Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis. | Transplant Cell Ther | 2022 | 35158092 | PubTator, text mining | PubMed |
| SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer. | J Biol Chem | 2022 | 35157849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=54